Athira Pharma, Inc.
ATHA
$0.295
-$0.008-2.64%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
6/6/2025
-
Ticker Report
6/2/2025
-
TipRanks Financial Blog
5/13/2025
-
GuruFocus
5/13/2025
-
GuruFocus
5/13/2025
-
GuruFocus
5/13/2025
-
TipRanks Financial Blog
5/13/2025
-
The Fly
5/13/2025
-
Globe Newswire
5/10/2025
-
TipRanks Financial Blog
5/9/2025
-
GuruFocus
5/9/2025
-
GuruFocus
5/9/2025
-
Globe Newswire
5/7/2025
-
Simply Wall St
3/1/2025
-
TipRanks Financial Blog
2/27/2025
-
Ticker Report
2/27/2025
-
GuruFocus
2/27/2025
-
GuruFocus
2/27/2025
-
The Fly
2/27/2025
-
The Fly
2/27/2025
-
Globe Newswire
2/18/2025
-
Ticker Report
2/16/2025
-
Ticker Report
1/17/2025
-
Simply Wall St
1/8/2025
-
BizJournals.com - Nat'l Business News
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, May 9, 2025
Period Date
Monday, March 31, 2025
Next Filing
Beginning of August (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
425 620 8501
Address
18706 North Creek Parkway
Bothell, WA 98011
Bothell, WA 98011
Country
Year Founded
Business Description
Sector
Athira Pharma, Inc., clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its product pipeline includes ATH-1105...
more